Large Steam Sterilizer segmentation by application reflects the distinct regulatory and operational requirements of four major end‑user groups: hospitals, pharmaceutical manufacturing, biotechnology facilities, and research laboratories. Hospital installations, which include central sterile services departments (CSSDs), represent the largest share, driven by continuous demand for surgical instrument turnover, strict infection‑control standards, and recurring equipment refresh cycles. Pharmaceutical manufacturers prioritize batch‑size scalability and compliance with cGMP and USP <797> guidelines, allocating a substantial portion of the market to high‑throughput, validated sterilizers that support aseptic filling lines. Biotechnology firms, particularly those engaged in cell‑therapy and biologics production, require flexible cycle programming and validated sterility assurance levels, positioning them as a fast‑growing niche within the market. Research laboratories, while representing the smallest volume, demand compact yet reliable units for occasional sterilization of consumables and small instrument sets, often opting for modular designs. The distribution of these application segments shapes the overall market size, with each sector contributing uniquely to revenue growth and technology adoption trends in the Large Steam Sterilizer market.